CO5180620A1 - Proceso para la produccion de compuestos farmaceuticamente activos, particularmente derivados de acido quinolincarboxilico con actividad bacteriana - Google Patents

Proceso para la produccion de compuestos farmaceuticamente activos, particularmente derivados de acido quinolincarboxilico con actividad bacteriana

Info

Publication number
CO5180620A1
CO5180620A1 CO00065923A CO00065923A CO5180620A1 CO 5180620 A1 CO5180620 A1 CO 5180620A1 CO 00065923 A CO00065923 A CO 00065923A CO 00065923 A CO00065923 A CO 00065923A CO 5180620 A1 CO5180620 A1 CO 5180620A1
Authority
CO
Colombia
Prior art keywords
production
chinolincarboxyl
acid
active compounds
pharmaceutically active
Prior art date
Application number
CO00065923A
Other languages
English (en)
Inventor
Trevor John Grinter
Simon Howie
Original Assignee
Sb Pharmco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sb Pharmco Inc filed Critical Sb Pharmco Inc
Publication of CO5180620A1 publication Critical patent/CO5180620A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Un compuesto de la fórmula (I):<EMI FILE="00065923_1" ID="1" IMF=JPEG >Un proceso para la producción de un compuesto de la fórmula (III), o una sal y/o hidrato farmacéuticamente aceptable de lo mismo.<EMI FILE="00065923_2" ID="2" IMF=JPEG >en donde R es según se define para la fórmula (I) en la reivindicación 1, que consiste en la reacción de un compuesto de la fórmula (I) tal como se define en la reivindicación 1, con un compuesto de la fórmula (IV) :<EMI FILE="00065923_3" ID="3" IMF=JPEG >en donde X es un grupo saliente, y opcionalmente formar una sal y/o un hidrato farmacéuticamente aceptable de lo mismo.
CO00065923A 1999-09-03 2000-09-01 Proceso para la produccion de compuestos farmaceuticamente activos, particularmente derivados de acido quinolincarboxilico con actividad bacteriana CO5180620A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9920919.9A GB9920919D0 (en) 1999-09-03 1999-09-03 Novel compound

Publications (1)

Publication Number Publication Date
CO5180620A1 true CO5180620A1 (es) 2002-07-30

Family

ID=10860355

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00065923A CO5180620A1 (es) 1999-09-03 2000-09-01 Proceso para la produccion de compuestos farmaceuticamente activos, particularmente derivados de acido quinolincarboxilico con actividad bacteriana

Country Status (30)

Country Link
US (3) US6703512B1 (es)
EP (1) EP1212321B1 (es)
JP (1) JP4208463B2 (es)
KR (1) KR100705363B1 (es)
CN (1) CN1255402C (es)
AR (1) AR029452A1 (es)
AT (1) ATE270671T1 (es)
AU (1) AU773698B2 (es)
BR (1) BRPI0013750B8 (es)
CA (1) CA2383751C (es)
CO (1) CO5180620A1 (es)
CZ (1) CZ2002759A3 (es)
DE (1) DE60012028T2 (es)
DK (1) DK1212321T3 (es)
ES (1) ES2223570T3 (es)
GB (1) GB9920919D0 (es)
HK (1) HK1046908B (es)
HU (1) HU229391B1 (es)
IL (2) IL148441A0 (es)
MX (1) MXPA02002356A (es)
MY (1) MY126789A (es)
NO (1) NO322501B1 (es)
NZ (1) NZ517601A (es)
PL (1) PL206491B1 (es)
PT (1) PT1212321E (es)
SI (1) SI1212321T1 (es)
TR (1) TR200200548T2 (es)
TW (1) TWI264435B (es)
WO (1) WO2001017961A2 (es)
ZA (1) ZA200201779B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281817C (en) * 1999-06-29 2008-07-29 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
JP2005500350A (ja) 2001-08-02 2005-01-06 エルジー ライフサイエンス リミテッド ４−アミノメチレン−ピロリジン−３−オンおよび／または４−アミノメチレン−ピロリジン−３−アルコキシイミノ誘導体のアミノ保護誘導体、および／またはジェミフロキサシンまたはその塩の製造方法
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
DE60302472T2 (de) * 2002-07-17 2006-04-13 Ciba Speciality Chemicals Holding Inc. Oxidationsverfahren zur herstellung von chinacridonpigmenten
KR100653334B1 (ko) 2003-03-07 2006-12-04 주식회사 엘지생명과학 4-아미노메틸-3-알콕시이미노피롤리딘 메탄설폰산염의 신규한 제조 방법
US8822934B2 (en) * 2006-11-03 2014-09-02 Accuray Incorporated Collimator changer
CN104693088B (zh) * 2013-12-06 2018-01-05 常州市勇毅生物药业有限公司 一种吉米沙星侧链的制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57134482A (en) 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
IN162769B (es) 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH01100165A (ja) 1987-10-13 1989-04-18 Shionogi & Co Ltd オキシムまたはヒドロキシアミン誘導体系抗菌剤
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
JPH0356479A (ja) 1989-07-24 1991-03-12 Takeshi Yokota 水溶性キノロン誘導体のｐ‐トルエンスルホン酸塩
WO1991002526A1 (en) 1989-08-16 1991-03-07 Pfizer Inc. Azabicyclo quinolone carboxylic acids
US5137892A (en) 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
EP0541086A1 (en) 1991-11-08 1993-05-12 Kaken Pharmaceutical Co., Ltd. Antibacterial 6-fluoro-quinolones having an oxime group on the substituent in position 7
JPH0673056A (ja) 1992-08-26 1994-03-15 Kaken Pharmaceut Co Ltd キノリンカルボン酸誘導体およびその塩
US5776944A (en) 1994-06-16 1998-07-07 Lg Chemical Ltd. 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
DK0688772T3 (da) 1994-06-16 1999-11-01 Lg Chemical Ltd Quinolincarboxylsyrederivater med 7-(4-aminomethyl-3-oxim)-pyrrolidinsubstituenter og fremgangsmåde til deres fremstilling
JP3449658B2 (ja) 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法
US5763454A (en) 1995-06-06 1998-06-09 Pfizer, Inc. Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
IL122649A (en) 1995-08-11 2001-08-26 Pfizer (1s, 2s) - 1- (4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol methanesulfonate trihydrate, its use in the preparation of medicaments and pharmaceutical compositions comprising same
CA2250395C (en) 1996-03-29 2005-09-06 Smithkline Beecham Corporation Eprosartan dihydrate and a process for its production and formulation
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
KR100286874B1 (ko) 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
WO1999061420A1 (en) 1998-05-29 1999-12-02 Pharmacia & Upjohn Company 3-[(1--n-methylamino)ethyl-n-benzyl] pyrrolidine monomethanesulfonate
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
ATE383157T1 (de) 1999-06-29 2008-01-15 Lg Life Sciences Ltd Verwendung von gemifloxacin verbindungen gegen bakterien
EP1401440A4 (en) 1999-09-01 2006-07-05 Lg Life Sciences Ltd METHODS OF USING FLUOROQUINOLONE COMPOUNDS AGAINST BACTERIA
GB9920919D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
EP1561465A3 (en) 1999-09-22 2005-12-21 LG Life Sciences, Ltd. Methods of use of fluoroquinolone compounds against bacteria
KR20010091379A (ko) 2000-03-15 2001-10-23 성재갑 7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
KR20020018560A (ko) 2000-09-01 2002-03-08 성재갑 3-아미노메틸-4-ｚ-메톡시이미노피롤리딘의 신규 제조방법

Also Published As

Publication number Publication date
WO2001017961A2 (en) 2001-03-15
NO20021043L (no) 2002-03-01
BR0013750B1 (pt) 2014-06-17
JP4208463B2 (ja) 2009-01-14
NO20021043D0 (no) 2002-03-01
KR100705363B1 (ko) 2007-04-10
US6703512B1 (en) 2004-03-09
EP1212321B1 (en) 2004-07-07
HUP0202733A3 (en) 2005-12-28
US20040138292A1 (en) 2004-07-15
US6803467B2 (en) 2004-10-12
KR20020041423A (ko) 2002-06-01
HK1046908A1 (en) 2003-01-30
ES2223570T3 (es) 2005-03-01
TWI264435B (en) 2006-10-21
GB9920919D0 (en) 1999-11-10
JP2003508517A (ja) 2003-03-04
BR0013750A (pt) 2002-05-21
US20050033064A1 (en) 2005-02-10
BRPI0013750B8 (pt) 2021-05-25
CN1372558A (zh) 2002-10-02
CA2383751A1 (en) 2001-03-15
TR200200548T2 (tr) 2002-09-23
ATE270671T1 (de) 2004-07-15
CZ2002759A3 (cs) 2002-06-12
HU229391B1 (hu) 2013-11-28
PT1212321E (pt) 2004-10-29
EP1212321A2 (en) 2002-06-12
ZA200201779B (en) 2003-08-27
WO2001017961A3 (en) 2001-09-20
DE60012028D1 (de) 2004-08-12
DE60012028T2 (de) 2005-08-18
CN1255402C (zh) 2006-05-10
MXPA02002356A (es) 2002-07-30
PL206491B1 (pl) 2010-08-31
DK1212321T3 (da) 2004-10-25
HK1046908B (zh) 2005-05-27
IL148441A (en) 2007-03-08
NZ517601A (en) 2003-08-29
AR029452A1 (es) 2003-07-02
NO322501B1 (no) 2006-10-16
IL148441A0 (en) 2002-09-12
CA2383751C (en) 2010-06-29
PL354725A1 (en) 2004-02-09
HUP0202733A2 (hu) 2003-01-28
SI1212321T1 (en) 2004-12-31
AU6857300A (en) 2001-04-10
MY126789A (en) 2006-10-31
AU773698B2 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
CO5271657A1 (es) Derivados de azaindol
CO5460265A1 (es) Compuestos quimicos
CO5251404A1 (es) Compuestos antibioticos de azalida
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
CA2384283A1 (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
CO5280070A1 (es) Compuestos, composiciones farmaceuticas de indazol y metodos para mediar o inhibir la proliferacion celular
MY117968A (en) Process for the production of an aqueous monoester peroxycarboxylic acid solution, the solution obtainable by this process, and its use as disinfectant
JP2005533050A5 (es)
CO5180620A1 (es) Proceso para la produccion de compuestos farmaceuticamente activos, particularmente derivados de acido quinolincarboxilico con actividad bacteriana
EP1038875A3 (en) Imidazopyridine derivatives and process for making them
SE9904108D0 (sv) Nya föreningar
CA2531167A1 (en) Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
CO5150166A1 (es) (s)-10, 11-dihidro-3[2-(5,6,7,8-tetrahidro-1,8-naftiridin -2-il)-etoxi]-5h-dibenzo [a,d] cicloheptano-10-acido acetico
DE602004020632D1 (de) Verfahren zur herstellung einer alpha-1-antitrypsinlösung
CO5470281A1 (es) Procedimiento de sintesis mejorado de derivados de acido naftiridin-3-carboxilico
ECSP003680A (es) Proceso para derivados del acido fenilacetico
MY118573A (en) Method for inhibiting polymerization of a vinyl compound
AU2002220596A1 (en) Synthesis of r(+)alpha-lipoic acid
EA200000924A2 (ru) СПОСОБ ПОЛУЧЕНИЯ ПИРАЗОЛО[4,3-d]ПИРИМИДИН-7-ОН-3-ПИРИДИЛСУЛЬФОНИЛЬНЫХ СОЕДИНЕНИЙ И ИХ ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
CO5261576A1 (es) Compuestos
BRPI0000967A (pt) processos para preparação de compostos secretagogos de hormônio de crescimento
ATE299862T1 (de) Verfahren zur herstellung von ketiminen
CA2366600A1 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
UY26435A1 (es) Compuestos bis-básicos como inhibidores de triptasa, procedimiento para su preparación y su utilización como medicamentos.
HK1079198A1 (en) Nobel process for the preparation of pyrazolopyrimidiones

Legal Events

Date Code Title Description
FG Application granted